RANDI NIELSEN: Open Payments
NPI 1437530656 · HERMISTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 15 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $414 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $119 |
| Teva Pharmaceuticals USA, Inc. | 3 | $88 |
| E.R. Squibb & Sons, L.L.C. | 2 | $73 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Alkermes, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, COBENFY, AUSTEDO XR, INGREZZA, UZEDY, CAPLYTA, ARISTADA.
Industry payments across OR — which companies pay providers there.
